Skip to main content
SpringerLink
Log in

Tumor Angiogenesis in Cancers: Expression of CD105 Marker

  • Chapter
  • First Online:
Book cover Methods of Cancer Diagnosis, Therapy, and Prognosis

Part of the book series: Methods of Cancer Diagnosis, Therapy and Prognosis ((HAYAT,volume 7))

Abstract

Angiogenesis is an important step in the process of cancer growth and wound healing (Folkman 1971). Cancer is always accompanied by angiogenesis. Angiogenesis is a complex of endothelial cell growth through an interaction of growth factors and their ligands and of sustaining matrices. Several sources of vascular endothelium are thought to participate in angiogenesis: sprouting from the preexisting blood vessel or mobilization from the bone marrow and circulation in the blood stream, and anchoring and colonization at the lesion (Asahara et al. 1999; Gunsilius et al. 2000). Whatever the source of angiogenic cells, endothelial cells express specific molecules and proliferate through an interaction with their ligands. In this chapter, the morphologic features of tumor angiogenesis, general endothelial markers of endothelium, and proliferation specific molecule CD105 are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 349.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, and Isner JM (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228

    Article  CAS  PubMed  Google Scholar 

  • Behrem S, Zarkovic K, Eskinja N, and Jonjic N (2005) Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. Croat Med J 46:417-422

    PubMed  Google Scholar 

  • Bottela LM, Sanchez-Elsner T, Sanz-Rodriguez F, Kojima S, Shimada J, Guerrero-Esteo M, Cooreman MP, Ratziu V, Longo C, Vary CPH, Ramirez JR, Friedman S, and Bernabeu C (2002) Transcriptional activation of endoglin and transforming growth factor-β signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood 100:4001-4010

    Article  Google Scholar 

  • Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, Letarte M, Vitetta ES, and Thorpe PE (1995) Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1:1623-1634

    CAS  PubMed  Google Scholar 

  • Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, and Brown PO (2003) Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci 100:10623-10628

    Article  CAS  PubMed  Google Scholar 

  • Dales JP, Garcia S, Andrac L, Carpentier S, Ramuz O, Lavaut MN, Allasia C, Bonnier P, and Charpin C (2004) Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome. Int J Oncol 24:1197-1204

    PubMed  Google Scholar 

  • Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, and Akhurst RJ (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845-1854

    CAS  PubMed  Google Scholar 

  • Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, and Kumar S (2006) Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Hum Pathol 37:861-866

    Article  CAS  PubMed  Google Scholar 

  • Duff SE, Li C, Garland JM, and Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:984-992

    Article  CAS  PubMed  Google Scholar 

  • Faviana P, Boldrini L, Spisni R, Berti P, Galleri D, Biondi R, Camacci T, Materazzi G, Pingitore R, Miccoli P, and Fontanini G (2002) Neoangio­genesis in colon cancer: correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression. Oncol Rep 9:617-620

    CAS  PubMed  Google Scholar 

  • Ferrara N (2002) VEGF and the quest for tumor angiogenesis factors. Nat Rev Cancer 2:795-803

    Article  CAS  PubMed  Google Scholar 

  • Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186

    Google Scholar 

  • Fonsatti E, Jekunen AP, Kairemo KJA, Coral S, Snellman M, Nicotra MR, Natali PG, Altomonte M, and Maio M (2000) Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin Cancer Res 6:2037-2043

    CAS  PubMed  Google Scholar 

  • Fonsatti E, Altomonte M, Nicotra MR, Natali PG, and Maio M (2003) Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 22:6557-6563

    Article  CAS  PubMed  Google Scholar 

  • Fonsatti E, and Maio M (2004) Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med 2:18

    Article  PubMed  Google Scholar 

  • Fox SB, Harris AL (2004) Histological quantitation of tumour angiogenesis. APMIS 112:413-430

    Article  PubMed  Google Scholar 

  • Graulich W, Nettelbeck DM, Fischer D, Kissel T, and Muller R (1999) Cell type specificity of the human endoglin promoter. Gene 227:55-62

    Article  CAS  PubMed  Google Scholar 

  • Gunsilius E, Duba HC, Petzer AL, Kahler CM, Grunewald K, Stockhammer G, Gabl C, Dirnhofer S, Clausen J, and Gastl G (2000) Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355:1688-1691

    Article  CAS  PubMed  Google Scholar 

  • Hayat MA (2002) Microscopy, immunohistochemistry, and antigen retrieval methods. Kluwer Academic/Plenum Publishers, New York

    Google Scholar 

  • Hayat MA (ed) (2004-2006) Immunohistochemistry and in situ hybridization of human carcinomas, vols 1-4. Elsevier/Academic Press, San Diego, CA

    Google Scholar 

  • Hicklin DJ, and Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011-1027

    Article  CAS  PubMed  Google Scholar 

  • Jerkic M, Rivas-Elena JV, Prieto M, Carro R, Sanz-Rodriguez F, Perez-Barriocanal F, Rodriguez-Barbero A, Bernabeu C, Lopez-and Novoa JM (2004) Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 18:609-611

    CAS  PubMed  Google Scholar 

  • Lee SH, Mizutani N, Mizutani M, Luo Y, Zhou H, Kaplan C, Kim SW, Xiang R, and Reisfeld RA (2006) Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer. Cancer Immunol Immunother 55:1565-1574

    Article  CAS  PubMed  Google Scholar 

  • Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, and Wendel DP (1999) Defective angiogenesis in mice lacking endoglin. Science 284:1534-1537

    Article  CAS  PubMed  Google Scholar 

  • Maier JAM, Delia D, Thorpe PE, and Gasparini G (1997) In vitro inhibition of endothelial cell growth by the anti-angiogenic drug AGM-1470 (TNP-460) and the anti-endoglin antibody TEC-11. Anticancer Drugs 8:238-244

    Article  CAS  PubMed  Google Scholar 

  • Martone T, Rosso P, Albera R, Migliaretti G, Fraire F, Pignataro L, Pruneri G, Bellone G, and Cortesina G (2005) Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol 41:147-155

    Article  CAS  PubMed  Google Scholar 

  • Marx J (2007) Encouraging results for second-generation antiangiogenesis drugs. Science 308:1248-1249

    Article  Google Scholar 

  • Massi D, Franchi A, Paglierani M, Ketabchi S, Borgognoni L, Reali UM, and Santucci M (2004) Vasculogenic mimicry has no prognostic signi­ficance in pT3 and pT4 cutaneous melanoma. Hum Pathol 35:496-502

    Article  CAS  PubMed  Google Scholar 

  • McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, McCormick MK, Pericak-Vance MA, Heutink P, Oostra BA, Haitjema T, Westerman CJJ, Porteous ME, Guttmacher AE, Letarte M, and Mar-Chuk DA (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345-351

    Article  CAS  PubMed  Google Scholar 

  • Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, and Tokunaga O (2006a) Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch 448:127-134

    Article  CAS  PubMed  Google Scholar 

  • Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, and Tokunaga O (2006b) Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int 56:717-723

    Article  CAS  PubMed  Google Scholar 

  • Ogawa A, Miyazaki K, and Tokunaga T (1999) Distribution of newly formed vessels in human colorectal carcinomas with microangiography. Colorec Dis 1:88-100

    Article  Google Scholar 

  • Okada K, Satoh T, Fujimoto K, and Tokunaga O (2004) Interaction between morphology and angiogenesis in human early colorectal cancers. Pathol Int 54:490-497

    Article  PubMed  Google Scholar 

  • Saad RS, El-Gohary Y, Memari E, Liu YL, and Silverman JF (2005) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Hum Pathol 36:955-961

    Article  CAS  PubMed  Google Scholar 

  • Saito M, Sato Y, Watanabe J, Kuramoto H, Kabal S, and Fukuda T (2007) Angiogenic factors in normal endometrium and endometrial adenocarcinoma. Pathol Int 57:140-147

    Article  CAS  PubMed  Google Scholar 

  • Shia S-R, Richard J, Cotea RJ, and Taylora CR (1997) Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem 45:327-344

    Article  Google Scholar 

  • Takahashi N, Haba A, Matsuno F, and Seon BK (2001) Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin [CD105] monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Cancer Res 61:7846-7854

    CAS  PubMed  Google Scholar 

  • Taskiran C, Erdem O, Onan A, Arisoy O, Acar A, Vural C, Erdem M, Ataoglu O, and Guner H (2006) The prognostic value of endoglin (CD105) expression in ovarian carcinoma. Int J Gynecol Cancer 16:1789-1793

    Article  CAS  PubMed  Google Scholar 

  • Urness LD, Sorensen LK, and Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26:328-331

    Article  CAS  PubMed  Google Scholar 

  • Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL, and Dirix LY (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564-1579

    Article  CAS  PubMed  Google Scholar 

  • Wikstrom P, Lissbrant IF, Stattin P, Egevad L, and Bergh A (2002) Endoglin [CD105] is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 51:268-275

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Biodefense, Faculty of Medicine, Saga University, Nabeshima 5-1-1, Saga City, Saga, 849-8501, Japan

    Osamu Tokunaga, Rahmawati Minhajat & Daisuke Mori

Authors
  1. Osamu Tokunaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rahmawati Minhajat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daisuke Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Osamu Tokunaga .

Editor information

Editors and Affiliations

  1. Dept. Biological Sciences, Kean University, Union, 07083, USA

    M. A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Tokunaga, O., Minhajat, R., Mori, D. (2010). Tumor Angiogenesis in Cancers: Expression of CD105 Marker. In: Hayat, M. (eds) Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy and Prognosis, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3186-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-90-481-3186-0_3

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-3185-3

  • Online ISBN: 978-90-481-3186-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation